Magn Reson Med, July 2018
Using MRI Cell Tracking to Monitor Immune Cell Recruitment in Response to a Peptide-based Cancer Vaccine
Tremblay ML, Davis C, Bowen CV, Stanley O, Parsons C, Weir G, Karkada M, Stanford MM, Brewer KD.
J Biomed Sci., January 2018
Unique Depot Formed By an Oil-based Vaccine Facilitates Active Antigen Uptake and Provides Effective Tumour Control
Brewer KD, Weir GM, Dude I, Davis C, Parsons C, Penwell A, Rajagopalan R, Sammatur L, Bowen CV, Stanford MM. J Biomed Sci.
Hum Vaccin Immunother., January 2018
Type III Hypersensitivity Reactions to a B Cell Epitope Antigen are Abrogated Using a Depot Forming Vaccine Platform
MacDonald LD, MacKay A, Kaliaperumal V, Weir GM, Penwell A, Rajagopalan R, Langley JM, Halperin S, Mansour M, Stanford MM. Hum Vaccin Immunother.
J Immunother Cancer., October 2016
Anti-PD-1 Increases the Clonality and Activity of Tumor Infiltrating Antigen Specific T cells Induced by a Potent Immune Therapy Consisting of Vaccine and Metronomic Cyclophosphamide
Weir GM, Hrytsenko O, Quinton T, Berinstein NL, Stanford MM, Mansour M.
Mol Ther Methods Clin Dev, December 2015
Using MRI to Evaluate and Predict Therapeutic Success From Depot-based Cancer Vaccines
DeBay DR, Brewer KD, LeBlanc SA, Weir GM, Stanford MM, Mansour M, Bowen CV.
Oncoimmunology., May 2015
Survivin-targeted Immunotherapy Drives Robust Polyfunctional T cell Generation and Differentiation in Advanced Ovarian Cancer Patients
Berinstein NL, Karkada M, Oza AM, Odunsi K, Villella JA, Nemunaitis JJ, Morse MA, Pejovic T, Bentley J, Buyse M, Nigam R, Weir GM, MacDonald LD, Quinton T, Rajagopalan R, Sharp K, Penwell A, Sammatur L, Burzykowski T, Stanford MM, Mansour M.
Vaccine, December 2014
Clearance of Depot Vaccine SPIO-labeled Antigen and Substrate Visualized Using MRI
Brewer KD, Lake K, Pelot N, Stanford MM, DeBay DR, Penwell A, Weir GM, Karkada M, Mansour M, Bowen CV.
OncoImmunology, November 2014
Metronomic Cyclophosphamide Enhances HPV16E7 Peptide Vaccine Induced Antigen-specific and Cytotoxic T-cell Mediated Antitumor Immune Response
Weir GM, Hrytsenko O, Stanford MM, Berinstein NL, Karkada M, Liwski RS, Mansour M.
ISRN Oncology, March 2013
Tumor Inhibition by DepoVax-based Cancer Vaccine is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor Infiltration
Karkada M, Quinton T, Blackman R, Mansour M.
J Trans Med., August 2012
First-in-man Application of a Novel Therapeutic Cancer Vaccine Formulation With the Capacity to Induce Multi-functional T Cell Responses in Ovarian, Breast and Prostate Cancer Patients
Berinstein NL, Karkada M, Morse MA, Nemunaitis JL, Chatta G, Kaufman H, Odunsi K, Nigam R, Sammatur L, MacDonald LD, Weir GM, Stanford MM, Mansour M.